Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 4 (2017) CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva
"... half-life of telmisartan, which retains its effect for more than 24 hours. This is especially important ..."
 
Vol 16, No 4 (2020) How to Choose the Optimal Single-Pill Combination of the First-Line Antihypertensive Drugs? The Benefits of Amlodipine and Telmisartan Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, V. N. Butorov, I. F. Krotkova
"... hours), and also a decrease in BP variability. Therefore, amlodipine/telmisartan SPC can effectively ..."
 
Vol 15, No 6 (2019) Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... blocker. In both classes, the reference and the best representatives include, respectively, telmisartan ..."
 
Vol 11, No 6 (2015) Cardiometabolic properties of telmisartan: new perspectives for use Abstract  similar documents
O. M. Drapkina, E. I. Fomicheva
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... , are presented. The advantages of this drugs class are highlighted with the focus on telmisartan. Additionally ..."
 
Vol 17, No 1 (2021) Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review) Abstract  similar documents
O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko
"... example of the use of a fixed combination of angiotensin II receptor blocker telmisartan and calcium ..."
 
Vol 18, No 6 (2022) Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study Abstract  similar documents
F. T. Ageev, M. D. Smirnova
"... combinations (SPC) amlodipine + telmisartan and hydrochlorothiazide + telmisartan in clinical practice ..."
 
Vol 15, No 4 (2019) Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... conditions according to the new guidelines. In this regard, SPC of telmisartan and hydrochlorothiazide (HCT ..."
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... resistance, obesity, dyslipidemia is also covered. The evidence base for the use of telmisartan as a drug ..."
 
Vol 16, No 2 (2020) The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov
"... Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy ..."
 
Vol 5, No 2 (2009) EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
G. F. Andreeva, A. D. Deev, V. M. Gorbunov
"... and telmisartan during 1-3 months. 24-hour blood pressure (BP) monitoring, QoL was performed before and after ..."
 
Vol 5, No 1 (2009) EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina
"... indices. Analysis of peak and phase characteristics of 24 hour BP profile was used as well as standard ..."
 
Vol 12, No 2 (2016) COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS Abstract  similar documents
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya
"... /2 30.84±10.78 vs 29.59±12.08 hours, respectively). Blood pressure reduction was slightly more ..."
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... in the blood plasma 5.42 (5.26–5.76) vs 4.88 (4.86–4.94) hours, respectively; p<0.001. Original enalapril ..."
 
Vol 12, No 3 (2016) THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE Abstract  PDF (Eng)  similar documents
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko
"... .6 ng•h/mL (CV%=82), median Tmax 3 hours (min 1, max 4), mean t½ 16.9 h (SD 13.6). Negative correlation ..."
 
Vol 15, No 2 (2019) Cognitive impairment in patients with arterial hypertension: a relationship with the level and daily blood pressure profile and pathogenetic mechanisms Abstract  similar documents
T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova
"... , увеличение величины утреннего подъема АД. Патогенетические аспекты взаимосвязи когнитивных нарушений и АГ ..."
 
Vol 16, No 5 (2020) Pharmacokinetics and Pharmacogenetics of Apixaban Abstract  similar documents
A. V. Savinova, M. M. Petrova, N. A. Shnayder, E. N. Bochanova, R. F. Nasyrova
"... », «фармакокинетика», «фармакогенетика», «эффективность», «безопасность». Подробно рассмотрена фармакокинетика ..."
 
Vol 17, No 1 (2021) Pharmacokinetics and Pharmacogenetics of Dabigatran Abstract  similar documents
A. V. Savinova, V. S. Dobrodeeva, M. M. Petrova, R. F. Nasyrova, N. A. Shnayder
"... , лишен недостатков, свойственных антагонистам витамина К, но фармакокинетика и фармакогенетика ..."
 
Vol 19, No 5 (2023) Daily breakfast: will skipping a morning meal become a new prognostic marker? Abstract  similar documents
O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina
"... исследований, подтверждающие  важность утреннего приема пищи для здоровья. В статье представлены данные о ..."
 
Vol 7, No 1 (2011) INFLUENCE OF CHRONOTHERAPY WITH DIFFERENT ANTIHYPERTENSIVE DRUGS ON CIRCADIAN BLOOD PRESSURE PATTERN Abstract  similar documents
V. M. Gorbunov, E. Yu. Fedorova, A. D. Deev, O. Yu. Isaikina, V. G. Belolipetskaya, E. A. Zhabina
"... ; 3.8-4.3 for morning BP surge. The t-values of office and 24-hour BP were low (0.2-1.7). Conclusion ..."
 
Vol 13, No 5 (2017) CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM Abstract  similar documents
V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova
"... ,  and inconvenience of 48-hour BP monitoring. The currently available scientific information concerning advantages ..."
 
Vol 9, No 3 (2013) TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN Abstract  similar documents
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
 
Vol 1, No 2 (2005) PHARMACOKINETIC RESEARCHES AND PRACTICAL MEDICINE Abstract  similar documents
V. G. Belolipetskaya, Y. V. Sukhanov
"... В статье в доступной для практических врачей форме даются основные понятия о фармакокинетике как о ..."
 
Vol 11, No 1 (2015) ON THE SELECTION OF DRUGS DOSAGE REGIMEN Abstract  similar documents
E. N. Bochanova
"... Описывается сложная система регуляции гемостаза, недостаточные сведения о фармакокинетике ..."
 
Vol 4, No 1 (2008) COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE Abstract  similar documents
О. N. Antropova, I. V. Osipova, E. I. Kuznetzova, N. V. Piricova, I. I. Curbatova
"... nebivolol (1 group), enalapril (2 group) or indapamide (3 group). 24-hour BP monitoring, echocardiography ..."
 
Vol 19, No 5 (2023) White coat effect in patients with hypertension Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova
 
Vol 13, No 5 (2017) EFFECT OF LISINOPRIL ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS Abstract  similar documents
O. L. Sarkisova, N. V. Rebrova, I. I. Bogomolova, E. A. Anisimova, R. S. Karpov, V. F. Mordovin, T. G. Khruleva
"... .5±5.5 mg per day. Mean  dose  of lisinopril was 12.2±9.8 mg/day. Office BP measurements, 24-hour ..."
 
Vol 12, No 1 (2016) Features of pharmacotherapy in the elderly patients. Introduction to the problem Abstract  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... Обсуждаются особенности фармакотерапии пожилых пациентов. Представлены данные по фармакокинетике и ..."
 
Vol 19, No 3 (2023) Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report Abstract  similar documents
A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov
 
Vol 19, No 5 (2023) Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease Abstract  similar documents
N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev
 
Vol 10, No 1 (2014) CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN Abstract  similar documents
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov
"... Aim. To study changes in the parameters of the 24-hour blood pressure (BP) monitoring and arterial ..."
 
Vol 17, No 2 (2021) Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma Abstract  similar documents
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya
"... ), 24-hour monitoring ambulatory (ABPM), spirometry, clinical and biochemical blood tests, BA control ..."
 
Vol 5, No 1 (2009) CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. A. Anichkov, A. A. Platonova
"... factors and RA clinical characteristics, laboratory tests, 5-min and 24-hour ECG recordings. We analyzed ..."
 
Vol 12, No 6 (2016) EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND Abstract  similar documents
V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov
"... Aim. To study the changes in indicators of 24-hours blood pressure (BP) monitoring during ..."
 
Vol 5, No 4 (2009) EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE Abstract  similar documents
N. J. Borovkova, N. N. Borovkov, T. I. Maslov
"... blood pressure (BP) and 24-hour ambulatory BP monitoring (ABPM) were evaluated initially and in 12 ..."
 
Vol 17, No 1 (2021) Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide Abstract  similar documents
N. M. Gafurova, E. V. Shikh, O. D. Ostroumova
"... особенности пациента. Фармакогенетика торасемида может иметь существенное значение для фармакокинетики и ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
 
Vol 1, No 2 (2005) ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE Abstract  similar documents
P. P. Tikhonov, L. A. Sokolova
"... . Decrease in 24-hour BP, daytime and nighttime BP, burden with BP and BP variability during daytime ..."
 
Vol 18, No 6 (2022) Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis Abstract  similar documents
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev
"... Цель. Изучить влияние носительства гена ABCB1 и межлекарственных взаимодействий на фармакокинетику ..."
 
Vol 4, No 2 (2008) EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY Abstract  similar documents
A. V. Semenov, D. A. Sichev, V. G. Kukes
"... Цель. Оценить влияние полиморфизма генов SLCO1B1 и MDR1 на фармакокинетику и фармакодинамику ..."
 
Vol 5, No 5 (2009) LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE Abstract  similar documents
M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova
"... . Reduction of average 24-hour, day and night BP, BP load, rate of morning BP rising was observed. Negative ..."
 
Vol 14, No 6 (2018) Different Types of Blood Pressure Variability in Hypertensive Patients with Chronic Lower Airway Diseases Abstract  PDF (Eng)  similar documents
M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Ya. N. Koshelyaevskaya, A. D. Deev
"... . The assessment of 24-hour BPV and mid-term BPV was based on ABPM and HBPM, respectively. Results. The BPV levels ..."
 
Vol 13, No 4 (2017) CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS Abstract  similar documents
N. A. Karoli, A. P. Rebrov
"... .05), and hypoxemia (r=-0.76, p<0.01). We noted relationships between the parameters of 24-hour BP monitoring ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... with untreated HT, stage II, degree 1-2 (51.7% of men, aged 53.6±0.8 years) were examined. 24-hour BP monitoring ..."
 
Vol 5, No 4 (2009) BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES Abstract  similar documents
G. N. Gorokchovskaya, M. M. Petina
"... сердца. Более детально обсуждаются особенности применения бисопролола, обусловленные его фармакокинетикой ..."
 
Vol 13, No 3 (2017) PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION Abstract  similar documents
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko
"... антикоагулянтов, на фармакокинетику препаратов данной группы. В исследовании RE-LY у носителей полиморфизма rs ..."
 
Vol 12, No 5 (2016) Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... фармакокинетики, наличия сопутствующих заболеваний и лекарственных взаимодействий пожилые пациенты более уязвимы в ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... через измерение отношения концентрации 6-β-гидроксикортизола к кортизолу (6-OHC/FC) в утренней моче ..."
 
Vol 13, No 2 (2017) OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE Abstract  similar documents
E. B. Babanskaya, L. V. Menshikova
"... препаратам являются недостаточными. Врачам необходима и интересна информация по фармакокинетике и ..."
 
Vol 8, No 3 (2012) THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN Abstract  similar documents
O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova
"... coronary syndrome (ACS) during first 6 hours after ACS symptoms onset were enrolled into the study ..."
 
Vol 14, No 6 (2018) Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 Abstract  PDF (Eng)  similar documents
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova
"... weeks of antihypertensive therapy, 24-hour blood pressure monitoring was performed, the indices ..."
 
Vol 3, No 4 (2007) EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova
"... на сосудистое ремоделирование. Метопролол уменьшал утренний подъем АД и частоту сердечных сокращений ..."
 
Vol 20, No 3 (2024) Theory and practice of selective imidazoline receptor agonist use in Russia Abstract  similar documents
N. I. Gaponova, V. R. Abdrakhmanov
"... повышенную вариабельность АД, способствуя нормализации суточного профиля АД, снижению утреннего подъема ..."
 
Vol 18, No 6 (2022) Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study Abstract  similar documents
K. V. Charaya, D. Yu. Shchekochikhin, S. N. Tarasenko, N. A. Ananicheva, S. A. Sovetova, T. V. Soboleva, O. N. Dikur, A. I. Borenstein, D. A. Andreev
"... hours after the first dose of a loop diuretic was administered in patients with acute decompensation ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... in a double-blind,-randomized, cross-over study. The change in 24-hour diuresis and natriuresis, fractional ..."
 
Vol 13, No 3 (2017) EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY Abstract  similar documents
V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya
"... spaces in bothLV and RV myocardium increases first after single epinephrine injection (after 2 hours ..."
 
Vol 7, No 5 (2011) ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS Abstract  similar documents
G. P. Arutyunov, L. G. Oganezova
"... in groups during 6 hours. Results. The frequency of target BP achievement in the urapidil treatment group ..."
 
Vol 5, No 1 (2009) CORRELATION OF STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE WITH AMBULATORY BLOOD PRESSURE MONITORING DATA IN PATIENTS WITH ESSENTIAL HYPERTENSION Abstract  similar documents
O. M. Khromtsova, M. V. Arkhipov
"... Aim. To evaluate the relationship of 24-hour blood pressure (BP) monitoring data with myocardial ..."
 
Vol 17, No 3 (2021) Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) Abstract  similar documents
N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin
"... изменения их фармакокинетики. Различий по клинико-демографическим характеристикам пациентов и оказании ..."
 
Vol 9, No 2 (2013) COMPARISON OF HEART RATE VARIABILITY ADJUSTED FOR AGE AND HEART RATE IN WOMEN WITH RHEUMATOID ARTHRITIS AND WOMEN WITHOUT RHEUMATIC DISEASES Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. I. Nasonov
"... Aim. To compare the 24-hour indicators of heart rate variability (HRV), adjusted for age and 24 ..."
 
Vol 3, No 2 (2007) ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY Abstract  similar documents
N. N. Nikitina, A. G. Avtandilov, K. R. Petrosyan, S. L. Petrosov
"... Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood ..."
 
Vol 16, No 2 (2020) The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease Abstract  similar documents
G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov
"... ; on the day of PCI – 20 mg 2 hours before intervention and 10 mg 6-12 hours after PCI; over the next 30 days ..."
 
Vol 12, No 2 (2016) ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME Abstract  similar documents
L. V. Kremneva, S. N. Suplotov, S. V. Shalaev
"... consider a 3-hour algorithm for myocardial infarction (MI) diagnostic, recommended by the expert group ..."
 
Vol 20, No 1 (2024) Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure Abstract  similar documents
A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
"... with different EECP treatment regimens for 12 months: Group 1 (n=40): course of 35 hour-long procedures; Group 2 ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... , непредсказуемость фармакодинамики и фармакокинетики у отдельных пациентов) способствовали поиску новых, более ..."
 
Vol 16, No 4 (2020) Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure Abstract  similar documents
N. M. Gafurova, E. V. Shikh, O. D. Ostroumova
"... повышенным риском повторных госпитализаций. В фармакокинетики петлевых диуретиков существуют значительные ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... антикоагулянтов, их фармакокинетика в той или иной мере меняется при снижении скорости клубочковой фильтрации, что ..."
 
Vol 20, No 4 (2024) Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension Abstract  similar documents
O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova
"... нарушенной функцией почек. В обзоре представлены данные об особенностях фармакодинамики и фармакокинетики ..."
 
Vol 7, No 3 (2011) COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY Abstract  similar documents
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko
"... to 50 mg 2 times a day. Duration of observation was 8 weeks. Results. Perindopril reduced 24-hour ..."
 
Vol 18, No 4 (2022) Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels Abstract  PDF (Eng)  similar documents
O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov
"... 06 hours, 6-12 hours, 12-18hours, 18-24 hours and more than 24 hours was12%, 14%, 62%, 5% and 7 ..."
 
Vol 18, No 6 (2022) The Pathogenetic Basis of the Action of Bempedoic Acid Abstract  similar documents
A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin
"... фармакодинамики и фармакокинетики бемпедоевой кислоты. В частности, после поступления в организм она должна быть ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE Abstract  similar documents
R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov
"... , индекс времени АД и величина утреннего повышения АД (с 37,6±2,0 до 23,9±1,9 мм рт. ст., p<0,001). Через ..."
 
Vol 8, No 5 (2012) CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION Abstract  similar documents
L. A. Bondarenko, L. E. Rudakova, F. K. Rakhmatullov, T. P. Kostrikova, I. I. Kapustina
"... analyzed. Results. The average time pain-thrombolysis was 2.7±0.22 hours. High efficacy of both ..."
 
Vol 5, No 2 (2009) THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY Abstract  PDF (Eng)  similar documents
O. V. Reshetko, N. V. Furman, R. M. Magdeev
"... coronary syndrome (ACS) without elevation ST during first 24 hours. Results. Prescription of drugs ..."
 
Vol 7, No 1 (2011) RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE Abstract  similar documents
R. Rajan, R. Natarajan, G. Vijayaraghavan
"... within 24 hours after symptom onset. This is one of the first cases of effective application ..."
 
Vol 17, No 2 (2021) Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness Abstract  similar documents
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
"... endpoints: restoration of sinus rhythm (SR) within 24 hours after the start of infusion of the study drug ..."
 
Vol 19, No 5 (2023) Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes Abstract  similar documents
A. M. Kochergina, O. L. Barbarash
"... Aim. To study the effect of azilsartan medoxomil (AZL-M) on the 24-hour blood pressure (BP ..."
 
Vol 17, No 3 (2021) New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  PDF (Eng)  similar documents
A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov
"... -hours urine spots and chronic kidney disease (CKD) progression pace in patients with atrial fibrillation ..."
 
Vol 12, No 3 (2016) EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva
"... ) <30 episodes per hour were included into group 1 and patients with AHI >30 episodes per hour ..."
 
Vol 6, No 4 (2010) COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov
"... hours after bisoprolol taking, 24-hour electrocardiogram-monitoring, evaluation of respiratory function ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... 1892 patients with STEMI diagnosed within 3 hours after onset of symptoms, and whom it was impossible ..."
 
Vol 7, No 1 (2011) ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
"... the fist administration and 2, 4, 8, 12, 24 hours and some next days after propafenone therapy start ..."
 
Vol 20, No 1 (2024) Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis Abstract  similar documents
l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev
"... CYP3A4*22 (rs35599367) C>T, CYP3A5*3 A>G, ABCB1 (rs1045642) C>T не влияло на фармакокинетику ..."
 
Vol 9, No 6 (2013) DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
"... into the study. Sinus rhythm (SR) was restored during the first 24 hours of hospitalization in all the pa- tients ..."
 
Vol 12, No 4 (2016) Organoprotective effects of serelaxin in patients with severe decompensated heart failure Abstract  similar documents
Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai
"... on the heart, kidneys, liver. 48-hour serelaxin infusion in patient with ischemic cardiomyopathy and severe ..."
 
Vol 4, No 5 (2008) AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov
"... (5-10 mg/day) therapy was started. ABPM, 24 hour electrocardiogram monitoring, echocardiography ..."
 
Vol 12, No 3 (2016) THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY Abstract  PDF (Eng)  similar documents
T. Y. Gromyko, S. A. Sayganov
"... rhythm recovery. Material and methods. Patients (n=153) with nonvalvular AF lasting from 24 hours to 6 ..."
 
Vol 8, No 6 (2012) MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE Abstract  similar documents
V. M. Gorbunov
"... ) or more complex formulas, including SD. BPV main varieties are considered a 24-hour BPV (measured ..."
 
Vol 6, No 1 (2010) ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN Abstract  similar documents
A. A. Fedorovich, A. N. Rogoza, E. M. Kanisheva, S. A. Boytsov
"... .v. during 2 hour infusion through the left cubital vein. Right forearm skin laser Doppler flowmetry (LDF ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... 80 mg for 12 hours and 2 hours before CABG in patients previously treated with atorvastatin 20 mg/day ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p<0.001). Duration ..."
 
Vol 6, No 6 (2010) PROGNOSTIC VALUE OF PATHOLOGIC Q-WAVE AND TIME OF ITS APPEARANCE IN PATIENTS WITH MYOCARDIAL INFARCTION: COMPARISON STUDY Abstract  similar documents
V. A. Shulman, S. E. Golovenkin, V. N. Simulin, V. V. Radionov, G. V. Matyushin
"... appearance. First group consisted of 311 patients with early Q-wave (during first 6 hours from onset of MI ..."
 
Vol 10, No 2 (2014) CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... enrolled in the study. Sinus rhythm (SR) was restored during the first 24 hours after admission in all ..."
 
Vol 14, No 2 (2018) IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE Abstract  similar documents
M. V. Lediakhova, S. N. Nasonova, I. V. Zhirov, M. V. Andreevskaya, R. M. Bogieva, T. M. Uskach, M. A. Saidova, V. P. Masenko, S. N. Tereshchenko
"... , the patients received an intravenous infusion of levosimendan 0.1 μg/kg/min for 24 hour added to standard ..."
 
Vol 2, No 2 (2006) CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION Abstract  similar documents
V. E. Oleynikov, V. A. Budanova, A. V. Kulucin
"... with starting data on 48 week of treatment significant reduction in 24-hour , day and night systolic blood ..."
 
Vol 12, No 1 (2016) Characteristic features, treatment and hospital outcomes in patients with acute myocardial infarction: Khabarovsk Register data. Part I Abstract  similar documents
L. N. Malay, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, H. B. Garayev, A. Ya. Letskin
"... .19% of patients with a reference AMI admitted to the vascular center in the first 6 hours, and 65.39% of patients ..."
 
Vol 20, No 2 (2024) Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina
"... (Omega-3 PUFAs) on the parameters of ambulatory blood pressure monitoring (ABPM), 24-hour ..."
 
1 - 100 of 196 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)